计算流体分析评估多层血流调节器治疗症状性慢性B型主动脉夹层
本研究基于多中心注册数据库12例症状性慢性B型主动脉夹层患者,采用计算流体动力学建模分析Streamliner多层血流调节器(SMFM)的血流动力学效应与分支通畅性。结果显示随访1年真腔体积增加、假腔体积和假腔指数下降,颈动脉和肾上段灌注显著提升,假腔壁压力降低,所有分支保持通畅。SMFM通过血流调节降低假腔壁压力,是治疗原发性症状性慢性B型主动脉夹层的可选方案。
要点
- SMFM通过血流调节降低假腔壁压力,促进主动脉重塑。
- 随访1年真腔体积增加,假腔体积和假腔指数下降。
- 颈动脉灌注增加35%±21%(P=.0216),肾上段灌注增加78%±32%(P=.001)。
核心结论
- SMFM通过血流调节降低假腔壁压力,保持所有分支通畅,减少短期并发症。
- SMFM是治疗原发性症状性慢性B型主动脉夹层的可选方案,中期无并发症。
研究设计与样本
- 从多层血流调节器全球注册(爱尔兰)多中心数据库获取12例症状性慢性B型主动脉夹层患者术前术后临床数据。
- 采用计算流体动力学建模进行生物力学分析,评估血流动力学效应和分支通畅性。
- 夹层平均长度30.23±13.3 cm,共使用30个SMFM,覆盖69个主动脉分支。
主要发现
- 随访1年,真腔体积从175.74±98.83 cm3增至209.87±128.79 cm3。
- 假腔体积从135.2±92.03 cm3降至123.19±110.11 cm3。
- 假腔指数从术前0.29±0.13降至术后0.21±0.15。
- 原发性SMFM治疗使颈动脉灌注增加35%±21%(P=.0216),肾上段灌注增加78%±32%(P=.001)。
- 假腔壁压力在原发性组(病例1-7)降低6.23%±4.81%,在继发性组(病例8-12)降低3.84%±2.59%。
临床怎么用
- 对于症状性慢性B型主动脉夹层,可考虑使用SMFM进行血流调节治疗。
- 治疗决策需结合计算流体动力学评估血流动力学效应和分支通畅性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Managing symptomatic chronic type B aortic dissection (SCTBAD) by the Streamliner Multilayer Flow Modulator (SMFM) stent (Cardiatis, Isnes, Belgium) is akin to provisional structural support to induce complete attachment of the dissection flap, but with the ability of aortic remolding. This study investigated the SMFM's capability to enact healing of SCTBAD. METHODS: Clinical data for 12 cases comprising preoperative and postoperative treatment of SCTBAD were obtained from a multicenter database hosted by the Multilayer Flow Modulator Global Registry, Ireland. A biomechanical analysis, by means of computational fluid dynamics modeling, of the hemodynamic effects and branch patency associated with the use of the SMFM was performed for all cases. The mean length of the dissections was 30.23 ± 13.3 cm. There were 30 SMFMs used, which covered 69 aortic branches. RESULTS: At 1-year follow-up, the true lumen volume increased from 175.74 ± 98.83 cm3 to 209.87 ± 128.79 cm3; the false lumen decreased from 135.2 ± 92.03 cm3 to 123.19 ± 110.11 cm3. The false lumen index decreased from 0.29 ± 0.13 (preoperatively) to 0.21 ± 0.15 (postoperatively). The primary SMFM treatment of SCTBAD increased carotid perfusion by 35% ± 21% (P = .0216) and suprarenal perfusion by 78% ± 32% (P = .001). The wall pressure distribution blended along the newly enlarged true lumen, whereas the false lumen wall pressure decreased by 6.23% ± 4.81% for the primary group (cases 1-7) and by 3.84% ± 2.59% for the secondary group (cases 8-12). CONCLUSIONS: SMFM reduces the false lumen wall pressure through flow modulation. It preserves patency of all branches, minimizing the incidence of short-term complications. The SMFM is a valuable option in managing primary SCTBAD, without midterm complications.
引用
- Stefanov F, Sultan S, Morris L, et al. Computational fluid analysis of symptomatic chronic type B aortic dissections managed with the Streamliner Multilayer Flow Modulator. J Vasc Surg. 2016. PMID: 27889286. doi:10.1016/j.jvs.2016.07.135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。